Phase 2 Futility Trials in Alzheimer Disease and Mild Cognitive Impairment
Authors:
- Aravind GaneshAGAravind Ganesh
- Eric E. SmithESEric E. Smith
- Jop MostertJMJop Mostert
- Eva M. StrijbisESEva M. Strijbis
- Menno M. SchoonheimMSMenno M. Schoonheim
- Chenjie XiaCXChenjie Xia
- Yannick NadeauYNYannick Nadeau
- Victoria M. LeavittVLVictoria M. Leavitt
- Lorraine V. KaliaLKLorraine V. Kalia
- Sebastiaan EngelborghsSESebastiaan Engelborghs
- Miguel D'HAeseleerMDMiguel D'HAeseleer
- 14 July 2026
- journal article
- Published by Wolters Kluwer Health in Neurology
- Vol. 107 (1) , e218227
Abstract
Background and ObjectivesThe cost and complexity of phase 2 randomized-controlled trials (RCTs) hinder further development of promising treatment candidates for Alzheimer disease (AD). The Simon Tw...Keywords
This publication has 33 references indexed in Scilit:
- Trends in Alzheimer’s Disease clinical outcome assessments in phase 2 and 3 clinical trials from 1993 to presentAlzheimer's & Dementia, 2024
- The ADNI PET Core at 20Alzheimer's & Dementia, 2024
- Minimal clinically important difference in Alzheimer's disease: Rapid reviewAlzheimer's & Dementia, 2024
- Donanemab in Early Symptomatic Alzheimer DiseaseJAMA, 2023
- 2023 Alzheimer's disease facts and figuresAlzheimer's & Dementia, 2023
- Improving generalizability and study design of Alzheimer's disease cohort studies in the United States by including under‐represented populationsAlzheimer's & Dementia, 2022
- The costs of developing treatments for Alzheimer's disease: A retrospective explorationAlzheimer's & Dementia, 2021
- Detection of Alzheimer's disease amyloid beta 1‐42, p‐tau, and t‐tau assaysAlzheimer's & Dementia, 2021
- Staging Dementia Using Clinical Dementia Rating Scale Sum of Boxes ScoresArchives of Neurology, 2008
- Mild Cognitive ImpairmentArchives of Neurology, 1999